세계의 엑소좀 기술 시장 보고서(2025년)

Exosome technologies involve the utilization of exosomes, which are small extracellular vesicles originating from endosomes, across diverse fields such as regenerative medicine, biotechnology, and biomedical research. This technology holds promise for applications in diagnostics, especially in liquid biopsy-based diagnostics and projects focused on discovering biomarkers. Exosomes, due to their unique characteristics, can serve as diagnostic biomarkers for the early identification of diseases.

Two primary types of exosome technologies are loaded cargo and non-cargo. Loaded cargo pertains to exosomes that have been modified to carry specific cargos, including therapeutic agents, employing passive or active loading methods. These engineered exosomes are derived from various cell sources such as HEK293 cells, mesenchymal stem cells (MSCs), platelets, erythrocytes, natural killer cells, and others. They find applications in both therapeutics and diagnostics, with end-users encompassing healthcare providers, pharmaceutical and biotechnology companies, and other entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The exosome technologies market research report is one of a series of new reports from The Business Research Company that provides exosome technologies market statistics, including exosome technologies industry global market size, regional shares, competitors with an exosome technologies market share, detailed exosome technologies market segments, market trends and opportunities, and any further data you may need to thrive in the exosome technologies industry. This exosome technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The exosome technologies market size has grown exponentially in recent years. It will grow from $0.07 billion in 2024 to $0.09 billion in 2025 at a compound annual growth rate (CAGR) of 26.1%. The growth in the historic period can be attributed to therapeutic advancements, isolation technique developments, research funding boosts, regenerative medicine exploration, and clinical trials inception.

The exosome technologies market size is expected to see exponential growth in the next few years. It will grow to $0.24 billion in 2029 at a compound annual growth rate (CAGR) of 27.8%. The growth in the forecast period can be attributed to regulatory progress, biomedical engineering innovations, clinical trials proliferation, regenerative medicine development, and nanotechnology integration growth. Major trends in the forecast period include therapeutic advancements, diagnostic applications, nanotechnology integration, research funding surge, and the development of isolation techniques.

The forecast of 27.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. regenerative medicine by increasing costs for exosome-based therapeutics and purification systems imported from Japan and Sweden, potentially delaying clinical trials and raising biotech development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the exosome technologies market is driven by the increasing prevalence of chronic diseases. Chronic diseases, characterized by persistent or long-lasting effects lasting three months or more, are on the rise, creating a demand for exosome technologies. These technologies play a crucial role in identifying disease-specific biomarkers, monitoring disease progression through exosome cargo analysis, facilitating targeted drug delivery, and immune modulation in chronic conditions. For instance, statistics from January 2023 indicate that the number of individuals aged 50 years and older with one or more chronic illnesses in the United States is projected to increase by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020. In Australia, an estimated 47% of the population, or 11.6 million individuals, are affected by at least one of the ten selected chronic ailments, as reported by the Australian Institute of Health and Welfare (AIHW) in July 2022. Hence, the escalating prevalence of chronic diseases is expected to drive the growth of the exosome technologies market.

Increasing healthcare expenditure is expected to drive the growth of the exosome technologies market in the coming years. Healthcare expenditure represents the total funds allocated to healthcare services, goods, and activities within a specific healthcare system or economy over a defined period. This rising expenditure is a key factor in advancing exosome technologies, as it supports research and development, enables reimbursement for clinical applications, bolsters chronic disease management efforts, and enhances infrastructure. For example, in December 2022, the U.S.-based Centers for Medicare & Medicaid Services reported that U.S. healthcare spending grew by 4.1% to reach $4.5 trillion, a rise from the 3.2% increase in 2021. Consequently, growing healthcare spending is fueling the expansion of the exosome technologies market.

The exosome technology market is witnessing a prominent trend in the adoption of advanced exosome characterization technologies. Companies within this market are integrating new technologies to maintain their competitive standing. For example, in August 2022, Creative Biolabs Inc., a biotech company based in the United States, introduced the NanosightTM platform for exosome characterization, leveraging Nanosight technology. Nanosight is a nanoparticle tracking analysis (NTA) technique enabling the visualization and quantification of exosomes based on their size and concentration. By offering this platform, Creative Biolabs intends to equip researchers with sophisticated tools for the comprehensive characterization and analysis of exosomes, facilitating a deeper understanding of their properties and functions.

Major players in the exosome technology sector are embracing a strategic partnership approach, seeking to capitalize on synergies and expedite progress in this dynamically evolving field. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutually beneficial outcomes. In June 2023, RoosterBio Inc., a biotechnology firm based in the United States, forged a partnership with Repligen, a life sciences company focused on bioprocessing. This collaboration aims to accelerate the development of scalable and cost-effective exosome bioprocessing solutions, ultimately enhancing accessibility to exosome-based therapies for patients.

In August 2024, BioIVT LLC, a U.S.-based provider of biospecimen solutions, acquired ZenBio Inc. for an undisclosed sum. This acquisition enables BioIVT to strengthen its expertise in cell and tissue models, expanding its portfolio of high-quality biological products for use in research and drug development. ZenBio Inc., also based in the U.S., is a biotechnology company specializing in human exosome research products.

Major companies operating in the exosome technologies market include AEGLE Therapeutics, Aruna Bio Inc., Carmine Therapeutics Inc., Exosome Diagnostics Inc., Creative Biolabs Inc., Danaher Corporation, OmniSpirant Limited, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Anjarium Biosciences, NOVADIP Biosciences S.A., Exopharm Ltd., Organicell Regenerative Medicine Inc., Evox Therapeutics, Direct Biologics, ExoCan Healthcare Technologies Pvt. Ltd., ExoCoBio, ExonanoRNA LLC, ILIAS Biologics Inc., Illumina Inc., Invitrix Therapeutics, XOStem Inc., VivaZome Therapeutics Pty Ltd., Aethlon Medical Inc., Capricor Therapeutics, Codiak BioSciences, Exogenus Therapeutics, Exovita Biosciences, HansaBioMed Life Sciences, Hitachi Chemical Advanced Therapeutics Solutions

North America was the largest region in the exosome technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global exosome technologies market report during the forecast period. The regions covered in the exosome technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the exosome technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The exosome technologies market consists of revenues earned by entities by providing exosome technologies services such as vaccine development, biomarker production, exosome-based diagnostic testing, and therapeutic development. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome technologies market consists of sales of exosome isolation kits, purification reagents, characterization tools, analysis kits, and exosome-based therapeutic products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exosome Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exosome technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exosome technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The exosome technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Exosome Type: Loaded Cargos; Non-Cargo
• 2) By Cell Source: HEK293 Cells; Mesenchymal Stem Cells (MSCs); Platelets; Erythrocytes; Natural Killer Cells; Other Cell Sources
• 3) By Application: Therapeutics; Diagnostics
• 4) By End-Users: Health Care Providers; Pharmaceutical And Biotechnology Companies; Other End-Users
• Subsegments:
• 1) By Loaded Cargo: Proteins; Nucleic Acids (DNA, RNA); Lipids; Small Molecules
• 2) By Non-Cargo: Exosome Membrane Components; Extracellular Matrix Components
• Companies Mentioned: AEGLE Therapeutics; Aruna Bio Inc.; Carmine Therapeutics Inc.; Exosome Diagnostics Inc.; Creative Biolabs Inc.; Danaher Corporation; OmniSpirant Limited; Thermo Fisher Scientific Inc.; Fujifilm Holdings Corporation; Anjarium Biosciences; NOVADIP Biosciences S.A.; Exopharm Ltd.; Organicell Regenerative Medicine Inc.; Evox Therapeutics; Direct Biologics; ExoCan Healthcare Technologies Pvt. Ltd.; ExoCoBio; ExonanoRNA LLC; ILIAS Biologics Inc.; Illumina Inc.; Invitrix Therapeutics; XOStem Inc.; VivaZome Therapeutics Pty Ltd.; Aethlon Medical Inc.; Capricor Therapeutics; Codiak BioSciences; Exogenus Therapeutics; Exovita Biosciences; HansaBioMed Life Sciences; Hitachi Chemical Advanced Therapeutics Solutions
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Exosome Technologies Market Characteristics

3. Exosome Technologies Market Trends And Strategies

4. Exosome Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Exosome Technologies Growth Analysis And Strategic Analysis Framework

• 5.1. Global Exosome Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Exosome Technologies Market Growth Rate Analysis
• 5.4. Global Exosome Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Exosome Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Exosome Technologies Total Addressable Market (TAM)

6. Exosome Technologies Market Segmentation

• 6.1. Global Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Loaded Cargos
• Non-Cargo
• 6.2. Global Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• HEK293 Cells
• Mesenchymal Stem Cells (MSCs)
• Platelets
• Erythrocytes
• Natural Killer Cells
• Other Cell Sources
• 6.3. Global Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics
• Diagnostics
• 6.4. Global Exosome Technologies Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Health Care Providers
• Pharmaceutical And Biotechnology Companies
• Other End-Users
• 6.5. Global Exosome Technologies Market, Sub-Segmentation Of Loaded Cargo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proteins
• Nucleic Acids (DNA, RNA)
• Lipids
• Small Molecules
• 6.6. Global Exosome Technologies Market, Sub-Segmentation Of Non-Cargo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exosome Membrane Components
• Extracellular Matrix Components

7. Exosome Technologies Market Regional And Country Analysis

• 7.1. Global Exosome Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Exosome Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Exosome Technologies Market

• 8.1. Asia-Pacific Exosome Technologies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Exosome Technologies Market

• 9.1. China Exosome Technologies Market Overview
• 9.2. China Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Exosome Technologies Market

• 10.1. India Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Exosome Technologies Market

• 11.1. Japan Exosome Technologies Market Overview
• 11.2. Japan Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Exosome Technologies Market

• 12.1. Australia Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Exosome Technologies Market

• 13.1. Indonesia Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Exosome Technologies Market

• 14.1. South Korea Exosome Technologies Market Overview
• 14.2. South Korea Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Exosome Technologies Market

• 15.1. Western Europe Exosome Technologies Market Overview
• 15.2. Western Europe Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Exosome Technologies Market

• 16.1. UK Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Exosome Technologies Market

• 17.1. Germany Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Exosome Technologies Market

• 18.1. France Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Exosome Technologies Market

• 19.1. Italy Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Exosome Technologies Market

• 20.1. Spain Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Exosome Technologies Market

• 21.1. Eastern Europe Exosome Technologies Market Overview
• 21.2. Eastern Europe Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Exosome Technologies Market

• 22.1. Russia Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Exosome Technologies Market

• 23.1. North America Exosome Technologies Market Overview
• 23.2. North America Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Exosome Technologies Market

• 24.1. USA Exosome Technologies Market Overview
• 24.2. USA Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Exosome Technologies Market

• 25.1. Canada Exosome Technologies Market Overview
• 25.2. Canada Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Exosome Technologies Market

• 26.1. South America Exosome Technologies Market Overview
• 26.2. South America Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Exosome Technologies Market

• 27.1. Brazil Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Exosome Technologies Market

• 28.1. Middle East Exosome Technologies Market Overview
• 28.2. Middle East Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Exosome Technologies Market

• 29.1. Africa Exosome Technologies Market Overview
• 29.2. Africa Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Exosome Technologies Market Competitive Landscape And Company Profiles

• 30.1. Exosome Technologies Market Competitive Landscape
• 30.2. Exosome Technologies Market Company Profiles
  • 30.2.1. AEGLE Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aruna Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Carmine Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Exosome Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Creative Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Exosome Technologies Market Other Major And Innovative Companies

• 31.1. Danaher Corporation
• 31.2. OmniSpirant Limited
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. Fujifilm Holdings Corporation
• 31.5. Anjarium Biosciences
• 31.6. NOVADIP Biosciences S.A.
• 31.7. Exopharm Ltd.
• 31.8. Organicell Regenerative Medicine Inc.
• 31.9. Evox Therapeutics
• 31.10. Direct Biologics
• 31.11. ExoCan Healthcare Technologies Pvt. Ltd.
• 31.12. ExoCoBio
• 31.13. ExonanoRNA LLC
• 31.14. ILIAS Biologics Inc.
• 31.15. Illumina Inc.

32. Global Exosome Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Exosome Technologies Market

34. Recent Developments In The Exosome Technologies Market

35. Exosome Technologies Market High Potential Countries, Segments and Strategies

• 35.1 Exosome Technologies Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Exosome Technologies Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Exosome Technologies Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer